Medtech InsightLumos Diagnostics ’ 510(k) application for FebriDx, an assay for differentiating viral and bacterial causes of upper respiratory tract infections, was turned down by the US Food and Drug Administratio
Medtech InsightThe pandemic has ushered in a new era in point-of-care (POC) testing in which technologies are increasingly becoming more accessible, more affordable and more convenient, putting the consumers’ needs